» Articles » PMID: 10377082

Familial Hypertrophic Cardiomyopathy in Maine Coon Cats: an Animal Model of Human Disease

Overview
Journal Circulation
Date 1999 Jun 22
PMID 10377082
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A naturally occurring animal model of familial hypertrophic cardiomyopathy (FHCM) is lacking. We identified a family of Maine coon cats with HCM and developed a colony to determine mode of inheritance, phenotypic expression, and natural history of the disease.

Methods And Results: A proband was identified, and related cats were bred to produce a colony. Affected and unaffected cats were bred to determine the mode of inheritance. Echocardiography was used to identify affected offspring and determine phenotypic expression. Echocardiograms were repeated serially to determine the natural history of the disease. Of 22 offspring from breeding affected to unaffected cats, 12 (55%) were affected. When affected cats were bred to affected cats, 4 (45%) of the 9 were affected, 2 (22%) unaffected, and 3 (33%) stillborn. Findings were consistent with an autosomal dominant mode of inheritance with 100% penetrance, with the stillborns representing lethal homozygotes that died in utero. Affected cats usually did not have phenotypic evidence of HCM before 6 months of age, developed HCM during adolescence, and developed severe HCM during young adulthood. Papillary muscle hypertrophy that produced midcavitary obstruction and systolic anterior motion of the mitral valve was the most consistent manifestation of HCM. Cats died suddenly (n=5) or of heart failure (n=3). Histopathology of the myocardium revealed myocardial fiber disarray, intramural coronary arteriosclerosis, and interstitial fibrosis.

Conclusions: HCM in this family of Maine coon cats closely resembles the human form of FHCM and should prove a valuable tool for studying the gross, cellular, and molecular pathophysiology of the disease.

Citing Articles

Prevalence of Hypertrophic Cardiomyopathy and ALMS1 Variant in Sphynx Cats in New Zealand.

Seo J, Loh Y, Connolly D, Luis Fuentes V, Dutton E, Hunt H Animals (Basel). 2024; 14(18).

PMID: 39335220 PMC: 11428990. DOI: 10.3390/ani14182629.


Genetic Basis of Hypertrophic Cardiomyopathy in Cats.

Grzeczka A, Graczyk S, Paslawski R, Paslawska U Curr Issues Mol Biol. 2024; 46(8):8752-8766.

PMID: 39194734 PMC: 11352635. DOI: 10.3390/cimb46080517.


Incomplete-penetrant hypertrophic cardiomyopathy G256E mutation causes hypercontractility and elevated mitochondrial respiration.

Lee S, Roest A, Blair C, Kao K, Bremner S, Childers M Proc Natl Acad Sci U S A. 2024; 121(19):e2318413121.

PMID: 38683993 PMC: 11087781. DOI: 10.1073/pnas.2318413121.


Serum C-terminal telopeptide of Type-I collagen (CTx) concentration and myocardial hyperechogenicity in cats with hypertrophic cardiomyopathy.

Anderson E, Cote E, Burton S, Saleh T Can Vet J. 2023; 64(9):864-870.

PMID: 37663017 PMC: 10426254.


Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C.

Stern J, Rivas V, Kaplan J, Ueda Y, Oldach M, Ontiveros E Sci Rep. 2023; 13(1):10319.

PMID: 37365215 PMC: 10293195. DOI: 10.1038/s41598-023-36932-5.